NCT05319158

Brief Summary

This study aims to assess the effect of a parent-administered intervention program based on MIT-PB in preterm with abnormal general movements during the preterm period. We will describe the short and long-term differences between infants exposed to MIT-PB and infants who follow current standard care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
11mo left

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Apr 2022Mar 2027

First Submitted

Initial submission to the registry

March 31, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

April 4, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 8, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Expected
Last Updated

December 10, 2024

Status Verified

December 1, 2024

Enrollment Period

4 years

First QC Date

March 31, 2022

Last Update Submit

December 5, 2024

Conditions

Keywords

neonatal therapygeneral movementshigh risk neurodevelopmentphysiotherapy

Outcome Measures

Primary Outcomes (1)

  • The quality of General Movement by General Movements Optimality Score (GMOS-R) and Motor Optimality Score (MOS).

    We will videotape General Movements at 34, 38-40, 44 and 54 weeks PMA. The baseline measure( 34w) will be performed by the main researcher and an independent and experienced certified rater. This rater will be blind regarding infant group. The assessments at 38-40, 44 and 54 weeks will be performed by the independent, blind and certified rater in order to guarantee the study validity. The GMOS-R global assessment can be Normal (N), Poor Repertoire (PR), Cramped Syncronized (CS) or Chaotic (CH). On the detailed score ,the maximum value is 38. The MOS global assessment can be classified as Fidgety (F), Abnormal Fidgety (AF) or Absent Fidgety (F-). On the detailed score the maximum value is 28. Higher scores in both scales are correlated with better global outcome.

    Each participant will be assessed from birth to the 54 weeks PMA.

Secondary Outcomes (2)

  • Motor development by Hammersmith Infant Neurological Scale (HINE).

    6 months CA

  • Global development by Bayley III

    12 months CA

Other Outcomes (2)

  • Describe families experiences with the MIT-PB

    6 months CA

  • Study family's participation and treatment adherence

    6 months CA

Study Arms (2)

Intervention group

EXPERIMENTAL

The group intervention will receive MIT-PB.

Other: MIT-PB, movement imitation therapy for preterm.

control group

NO INTERVENTION

The control group will receive standard care

Interventions

The instant an infant showed CS or PR movements, the therapists (or a therapist and a parent) intervened by gently guiding the infants' limbs so as to maneuver and smoothen their movements, thereby imitating normal GM sequences as closely as possible, adding variability to the movement

Intervention group

Eligibility Criteria

Age22 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants born before 32w GA and less than 1500g weight.
  • Infants who show Abnormal General Movements (CS-PR pattern) at 34-36w postmenstrual age (PMA).
  • Families able to understand/speak Catalan, Spanish or English.
  • Families willing to participate who have the informed consent

You may not qualify if:

  • Infants with congenital abnormalities and/or genetic disorders
  • Infants with invasive ventilation or Continuous Positive Airway Pressure (CPAP) at 36 weeks PMA.
  • Infants with Normal General Movements at 34-36 w PMA.
  • Families not willing to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hospital Sant Joan de Déu

Barcelona, Barcelona, 08950, Spain

RECRUITING

Hospital Parc Taulí de Sabadell

Sabadell, BARCELONA, 08208, Spain

RECRUITING

Hospital Universitari Josep Trueta de Girona

Girona, Girona, 17007, Spain

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Susana Trallero, MsC

    International University of Catalonia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Susana Trallero, MsC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessments for the main outcome will be performed by a blinded expert.
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: The infants will be pre-stratified according to General Movement Optimality Score (GMOs). The Control group will receive standard care and the Intervention groups will begin the therapy at 34-36w. The intervention will be explained and guided by the principal researcher and experienced Pediatric Physical therapist. Parents will conduct the intervention until the 50-52 weeks PMA. General Movement Assessment (GMA) will be performed at term, 44w and 54w PMA. Motor assessment will be carried out at 6 months Corrected Age (CA) and a global assessment at 12 months CA. Those assessments will be performed by independent and blind professionals at their corresponding Hospitals.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD candidate, MsC, Physiotherapist Susana Trallero Rodríguez

Study Record Dates

First Submitted

March 31, 2022

First Posted

April 8, 2022

Study Start

April 4, 2022

Primary Completion

March 31, 2026

Study Completion (Estimated)

March 31, 2027

Last Updated

December 10, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations